5-Amino-1MQ has been studied primarily in mouse models where it demonstrated notable fat loss, improved insulin sensitivity, and enhanced energy metabolism without reducing muscle mass
This growing body of evidence is what led Relive Health centers nationwide to offer NAD+ therapy with 5-Amino-1MQ, especially for adults over 40, whose NAD+ levels have already declined by up to 50% or more
More generally, the consensus of an international lipid expert panel is that evidence for use of either a single or combination lipid-lowering nutraceutical is limited and variable, but that berberine may have benefit for prevention, particularly in patients with mild hypercholesterolemia who are statin-intolerant or have metabolic syndrome (24)
AOD 9604 is not FDA-approved and is sold as a research compound
A comprehensive review on nutraceuticals: therapy support and formulation challenges
Glutathione operates by donating electrons to unstable molecules (free radicals), stabilising them and preventing cellular damage